Primary malignant neoplasm
|
0.040 |
AlteredExpression
|
group |
BEFREE |
Moreover, we found that HPV16-positive cancer cell lines exhibited lower KDM5C protein levels than HPV-negative cancer cell lines.
|
29339538 |
2018 |
Conventional (Clear Cell) Renal Cell Carcinoma
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Mutations in BAP1 negatively affected OS, whereas SETD2 and KDM5C mutations were associated with prolonged OS in our pooled cohort of 167 patients with metastatic ccRCC.
|
28408295 |
2017 |
Conventional (Clear Cell) Renal Cell Carcinoma
|
0.600 |
Biomarker
|
disease |
BEFREE |
We excluded the samples that had any of the five high-confidence driver genes (VHL, BAP1, SETD2, PTEN and KDM5C) reported in ccRCC to avoid their possible influence in our results.
|
27556922 |
2016 |
Movement Disorders
|
0.100 |
CausalMutation
|
group |
CLINVAR |
Patient Mutations of the Intellectual Disability Gene KDM5C Downregulate Netrin G2 and Suppress Neurite Growth in Neuro2a Cells.
|
27421841 |
2016 |
Dysmorphic features
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
Patient Mutations of the Intellectual Disability Gene KDM5C Downregulate Netrin G2 and Suppress Neurite Growth in Neuro2a Cells.
|
27421841 |
2016 |
Dysmorphic features
|
0.100 |
GeneticVariation
|
disease |
CLINVAR |
Patient Mutations of the Intellectual Disability Gene KDM5C Downregulate Netrin G2 and Suppress Neurite Growth in Neuro2a Cells.
|
27421841 |
2016 |
Overgrowth
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
Patient Mutations of the Intellectual Disability Gene KDM5C Downregulate Netrin G2 and Suppress Neurite Growth in Neuro2a Cells.
|
27421841 |
2016 |
Carcinogenesis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
We propose that RACK7/KDM5C functions as an enhancer "brake" to ensure appropriate enhancer activity, which, when compromised, could contribute to tumorigenesis.
|
27058665 |
2016 |
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE
|
0.910 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Different X-linked KDM5C mutations in affected male siblings: is maternal reversion error involved?
|
26919706 |
2016 |
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE
|
0.910 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Different X-linked KDM5C mutations in affected male siblings: is maternal reversion error involved?
|
26919706 |
2016 |
Intellectual Disability
|
0.600 |
Biomarker
|
group |
GENOMICS_ENGLAND |
We investigated a family of three boys with intellectual disability, and among them we identified two different mutations in KDM5C, located at Xp11.22, using whole-exome sequencing.
|
26919706 |
2016 |
Intellectual Disability
|
0.600 |
Biomarker
|
group |
GENOMICS_ENGLAND |
We investigated a family of three boys with intellectual disability, and among them we identified two different mutations in KDM5C, located at Xp11.22, using whole-exome sequencing.
|
26919706 |
2016 |
Global developmental delay
|
0.410 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Different X-linked KDM5C mutations in affected male siblings: is maternal reversion error involved?
|
26919706 |
2016 |
Global developmental delay
|
0.410 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Different X-linked KDM5C mutations in affected male siblings: is maternal reversion error involved?
|
26919706 |
2016 |
Epilepsy
|
0.330 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Different X-linked KDM5C mutations in affected male siblings: is maternal reversion error involved?
|
26919706 |
2016 |
Epilepsy
|
0.330 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Different X-linked KDM5C mutations in affected male siblings: is maternal reversion error involved?
|
26919706 |
2016 |
Developmental delay (disorder)
|
0.310 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Different X-linked KDM5C mutations in affected male siblings: is maternal reversion error involved?
|
26919706 |
2016 |
Developmental delay (disorder)
|
0.310 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Different X-linked KDM5C mutations in affected male siblings: is maternal reversion error involved?
|
26919706 |
2016 |
Hypothyroidism
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Different X-linked KDM5C mutations in affected male siblings: is maternal reversion error involved?
|
26919706 |
2016 |
Hypothyroidism
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Different X-linked KDM5C mutations in affected male siblings: is maternal reversion error involved?
|
26919706 |
2016 |
Progressive spasticity
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Different X-linked KDM5C mutations in affected male siblings: is maternal reversion error involved?
|
26919706 |
2016 |
Progressive spasticity
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Different X-linked KDM5C mutations in affected male siblings: is maternal reversion error involved?
|
26919706 |
2016 |
Movement Disorders
|
0.100 |
CausalMutation
|
group |
CLINVAR |
Different X-linked KDM5C mutations in affected male siblings: is maternal reversion error involved?
|
26919706 |
2016 |
Dysmorphic features
|
0.100 |
GeneticVariation
|
disease |
CLINVAR |
Different X-linked KDM5C mutations in affected male siblings: is maternal reversion error involved?
|
26919706 |
2016 |
Dysmorphic features
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
Different X-linked KDM5C mutations in affected male siblings: is maternal reversion error involved?
|
26919706 |
2016 |